title: [National level response to pandemic (H1N1) 2009].
abstract: The World Health Organization (WHO) announced the emergence of a novel influenza on April 24, 2009, and they declared pandemic on June 11. In Korea, the proportion of influenza-like illness and the consumption of antiviral agents peaked in early November. The government established the Central Headquarters for Influenza Control and operated the emergency response system. In the quarantine stations, we checked the body temperature and collected quarantine questionnaires from all the arrivals from infected countries. We also isolated the confirmed cases in the national isolation hospitals. However, as the community outbreaks were reported, we changed strategy from containment to mitigation. We changed the antiviral agent prescription guideline so that doctors could prescribe antiviral agents to all patients with acute febrile respiratory illness, without a laboratory diagnosis. Also the 470 designated hospitals were activated to enhance the efficacy of treatment. We vaccinated about 12 million people and manage the adverse event following the immunization management system. In 2010, we will establish additional national isolation wards and support hospitals to establish fever clinics and isolation intensive care unit (ICU) beds. We will also make a computer program for managing the national isolation hospitals and designated hospitals. We will establish isolation rooms and expand the laboratory in quarantine stations and we will construct a bio-safety level 3 laboratory in each province. In addition, we plan to construct a bio-safety level 4 laboratory at a new Korea Centers for Disease Control and Prevention (KCDC) facilities in Ossong.
authors.affiliation: Korea Centers for Disease Control and Prevention, Korea. ldhmd@korea.kr
authors.forename: Dong Han
authors.initials: DH
authors.lastname: Lee
authors.forename: Sang Sook
authors.initials: SS
authors.lastname: Shin
authors.forename: Byung Yool
authors.initials: BY
authors.lastname: Jun
authors.forename: Jong Koo
authors.initials: JK
authors.lastname: Lee
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D004189:Disaster Planning / Q000458:organization & administration*; D004196:Disease Outbreaks; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000188:drug therapy / Q000453:epidemiology*; D011790:Quarantine / Q000458:organization & administration; D056910:Republic of Korea / Q000453:epidemiology; D014944:World Health Organization
chemical_list: D000998:Antiviral Agents